View More Recent Stories

Jun 21, 2024 07:30AM Johnson & Johnson (JNJ) Completes Acquisition of Proteologix
Jun 20, 2024 04:31PM Johnson & Johnson (JNJ) Seeking FDA Approval of TREMFYA for Active Crohn's disease
Jun 18, 2024 09:45AM Stifel Comments on Johnson & Johnson (JNJ) Post EU Robotic Tour: 'JNJ’s laparoscopic surgery business continues to be on the losing end of robotic share gain'
Jun 17, 2024 08:02AM Johnson & Johnson (JNJ): Subcutaneous amivantamab BLA submitted to U.S. FDA for patients with EGFR-mutated non-small cell lung cancer
Jun 17, 2024 06:23AM RBC Capital Reiterates Outperform Rating on Johnson & Johnson (JNJ)
Jun 14, 2024 08:02AM Johnson & Johnson (JNJ) reports TALVEY demonstrated highly durable, longer-term responses in patients with relapsed or refractory multiple myeloma
Jun 11, 2024 05:27AM BofA Securities Reiterates Neutral Rating on Johnson & Johnson (JNJ)
Jun 10, 2024 05:39AM RBC Capital Reiterates Outperform Rating on Johnson & Johnson (JNJ)
Apr 14, 2024 02:00PM Johnson & Johnson (JNJ) stock: 1Q24 earnings preview
View More Recent Stories